UNSPSC 51111727: Amsacrine

This classification denotes an intercalating agent with the molecular formula C21H19N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00DPD30SOY, chemically known as methansulfon-m-aniside, 4-(9-acridinylamino)-, monohydrochloride but generally known as amsacrine, which bears US NIH Compound Identifier 2179. Amsacrine most often comes in hydrochloride and lactate forms. European Medicines Agency schedules Amsacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05495MIG.

UNSPSC 51111727 Amsacrine, a Commodity code, does not align with the recent state and local contract opportunities posted under this classification. The code nominally identifies a specific chemotherapy agent, but the four recent opportunities solicited under it involve naloxone and drug deactivation systems (Seminole County, Florida), therapeutic pharmacy initiatives and direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch between the code's pharmaceutical scope and the diversity of health and emergency-supply products actually being solicited suggests either misclassification in the posting systems or inconsistent tagging practices across state and local procurement offices.

The issuing bodies posting under this code span state health agencies, county government, city departments, and state-led cooperative purchasing alliances. Seminole County's IFB (due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the City of Tampa's ITB (due March 13, 2026, estimated contract value $700,000) covered 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division and is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; the Texas HHS Commission posted an RFI (response deadline April 3, 2026) on direct-to-manufacturer prescription programs; and MMCAP (administered by the Minnesota Department of Administration) issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across multiple states including Oregon. Recent activity spans Florida, Texas, and Minnesota, with no clear pattern of repeat buying under this code. Given the fundamental mismatch between the code definition and actual procurement content, vendors pursuing work in pharmaceutical supply, emergency medical supplies, or pharmacy benefit management should verify correct UNSPSC classification in each jurisdiction's procurement system before responding.